Surgery for gastric cancer: What the trials indicate

Surgical Oncology Clinics of North America

Volumn 21, Issue 1, 2012, Pages 79-97

  Hundahl, Scott A ^a  

^a VA NORTHERN CALIFORNIA HEALTH CARE SYSTEM   (United States)

Author keywords

Gastric cancer; Lymphadenectomy; Surgery; Trials

Indexed keywords

CANCER INCIDENCE; CANCER LOCALIZATION; CANCER MORTALITY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; COMPARATIVE EFFECTIVENESS; DIAGNOSTIC IMAGING; ENDOSCOPIC MUCOSAL RESECTION; GASTRECTOMY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; INTERMETHOD COMPARISON; LAPAROSCOPIC SURGERY; LAPAROTOMY; LYMPH NODE DISSECTION; METASTASIS; MORBIDITY; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; REVIEW; SPLENECTOMY; STOMACH CANCER; SURGICAL MORTALITY; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL RATE; TREATMENT PLANNING; TUMOR BIOPSY;

ASIA; CLINICAL TRIALS AS TOPIC; DISEASE-FREE SURVIVAL; EUROPE; FORECASTING; GASTRECTOMY; GASTROSCOPY; HUMANS; INCIDENCE; LAPAROSCOPY; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM STAGING; SOUTH AFRICA; STOMACH NEOPLASMS; UNITED STATES;

EID: 82955211562     PISSN: 10553207     EISSN: 15585042     Source Type: Journal    
DOI: 10.1016/j.soc.2011.09.005     Document Type: Review

References (70)

1. Schlemper R.J., Riddell R.H., Kato Y., et al. The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000, 47(2):251-255.
2. Japanese Gastric Cancer Association Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011, 14(2):101-112.
3. Ho C.L. Clinical PET imaging-an Asian perspective. Ann Acad Med Singapore 2004, 33(2):155-165.
4. Mochiki E., Kuwano H., Katoh H., et al. Evaluation of 18F-2-deoxy-2-fluoro-d-glucose positron emission tomography for gastric cancer. World J Surg 2004, 28(3):247-253.
5. Stahl A., Ott K., Weber W.A., et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003, 30(2):288-295.
6. Edge S.B., Compton C.C., Fritz A.G., et al. AJCC cancer staging manual 2009, Springer, New York. 7th edition.
7. Sobin L., Gospodarowicz M., Wittekind TNM Classification of Malignant Tumors 2009, Wiley-Blackwell, Indianapolis. Seventh Edition.
8. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg 1981, 11(2):127-139.
9. Sayegh M.E., Sano T., Dexter S., et al. TNM and Japanese staging systems for gastric cancer: how do they coexist?. Gastric Cancer 2004, 7(3):140-148.
10. Sano T., Aiko T. New Japanese classifications and treatment guidelines for gastric cancer: revision concepts and major revised points. Gastric Cancer 2011, 14(2):97-100.
11. Japanese Gastric Cancer Association Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011, 14(2):113-123.
12. Gouzi J.L., Huguier M., Fagniez P.L., et al. Total versus subtotal gastrectomy for adenocarcinoma of the gastric antrum. A French prospective controlled study. Ann Surg 1989, 209(2):162-166.
13. McNeer G., Pack G. Neoplasms of the Stomach 1967, Lippincott, Philadelphia.
14. McNeer G., Bowden L., Booner R.J., et al. Elective total gastrectomy for cancer of the stomach: end results. Ann Surg 1974, 180(2):252-256.
15. Bozzetti F. Surgical treatment of Borrmann type IV gastric carcinoma. J Am Coll Surg 1997, 185(2):200-201.
16. Bozzetti F., Marubini E., Bonfanti G., et al. Subtotal versus total gastrectomy for gastric cancer: five-year survival rates in a multicenter randomized Italian trial. Italian Gastrointestinal Tumor Study Group. Ann Surg 1999, 230(2):170-178.
17. Bozzetti F., Marubini E., Bonfanti G., et al. Total versus subtotal gastrectomy: surgical morbidity and mortality rates in a multicenter Italian randomized trial. The Italian Gastrointestinal Tumor Study Group. Ann Surg 1997, 226(5):613-620.
18. Robertson C.S., Chung S.C., Woods S.D., et al. A prospective randomized trial comparing R1 subtotal gastrectomy with R3 total gastrectomy for antral cancer. Ann Surg 1994, 220(2):176-182.
19. Ono H., Kondo H., Gotoda T., et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut 2001, 48(2):225-229.
20. Pathirana A., Poston G.J. Lessons from Japan-endoscopic management of early gastric and oesophageal cancer. Eur J Surg Oncol 2001, 27(1):9-16.
21. Sano T., Katai H., Sasako M., et al. The management of early gastric cancer. Surg Oncol 2000, 9(1):17-22.
22. Sasako M. Treatment of early gastric cancer. Chir Ital 1997, 49(3):9-13.
23. Hiki Y. Nippon Geka Gakkai Zasshi 1996, 97(4):273-278. [in Japanese].
24. Kobayashi T., Kazui T., Kimura T. Surgical local resection for early gastric cancer. Surg Laparosc Endosc Percutan Tech 2003, 13(5):299-303.
25. Yamamoto H., Sekine Y., Higashizawa T., et al. Successful en bloc resection of a large superficial gastric cancer by using sodium hyaluronate and electrocautery incision forceps. Gastrointest Endosc 2001, 54(5):629-632.
26. Yoshikane H., Sakakibara A., Hidano H., et al. Piecemeal endoscopic aspiration mucosectomy for large superficial intramucosal tumors of the stomach. Endoscopy 2001, 33(9):795-799.
27. Kobayashi T., Gotohda T., Tamakawa K., et al. Magnetic anchor for more effective endoscopic mucosal resection. Jpn J Clin Oncol 2004, 34(3):118-123.
28. Gotoda T., Oda I., Tamakawa K., et al. Prospective clinical trial of magnetic-anchor-guided endoscopic submucosal dissection for large early gastric cancer (with videos). Gastrointest Endosc 2009, 69(1):10-15.
29. Kuwano H., Mochiki E., Asao T., et al. Double endoscopic intraluminal operation for upper digestive tract diseases: proposal of a novel procedure. Ann Surg 2004, 239(1):22-27.
30. Gotoda T., Yanagisawa A., Sasako M., et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000, 3(4):219-225.
31. Ikehara H., Gotoda T., Ono H., et al. Gastric perforation during endoscopic resection for gastric carcinoma and the risk of peritoneal dissemination. Br J Surg 2007, 94(8):992-995.
32. Dent D.M., Madden M.V., Price S.K. Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma. Br J Surg 1988, 75(2):110-112.
33. Dent D.M. Radical surgery for curable gastric carcinoma. S Afr Med J 1994, 84(2):56-57.
34. Cuschieri A., Fayers P., Fielding J., et al. Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group. Lancet 1996, 347(9007):995-999.
35. Cuschieri A., Weeden S., Fielding J., et al. Patient survival after D1 and D2 resections for gastric cancer: long- term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer 1999, 79(9-10):1522-1530.
36. Bonenkamp J.J., Songun I., Hermans J., et al. Randomised comparison of morbidity after D1 and D2 dissection for gastric cancer in 996 Dutch patients. Lancet 1995, 345(8952):745-748.
37. Bonenkamp J.J., Hermans J., Sasako M., et al. Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 1999, 340(12):908-914.
38. Hartgrink H.H., Van De Velde C.J., Putter H., et al. Extended Lymph node dissection for gastric cancer: who may benefit? Final results of the Randomized Dutch Gastric Cancer Group Trial. J Clin Oncol 2004, 22:2069-2077.
39. Hartgrink H.H., van de Velde C.J. Status of extended lymph node dissection: locoregional control is the only way to survive gastric cancer. J Surg Oncol 2005, 90(3):153-165.
40. Songun I., Putter H., Kranenbarg E.M., et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010, 11(5):439-449.
41. Maruyama K., Sasako M., Kinoshita T., et al. Pancreas-preserving total gastrectomy for proximal gastric cancer. World J Surg 1995, 19(4):532-536.
42. Uyama I., Ogiwara H., Takahara T., et al. Spleen- and pancreas-preserving total gastrectomy with superextended lymphadenectomy including dissection of the para-aortic lymph nodes for gastric cancer. J Surg Oncol 1996, 63(4):268-270.
43. Kaminishi M., Shimoyama S., Yamaguchi H., et al. Results of subtotal gastrectomy with complete dissection of the N2 lymph nodes preserving the spleen and pancreas in surgery for gastric cancer. Hepatogastroenterology 1994, 41(4):384-387.
44. Wu C.W., Hsiung C.A., Lo S.S., et al. Nodal dissection for patients with gastric cancer: a randomised controlled trial. Lancet Oncol 2006, 7(4):309-315.
45. Wu C.W., Chang I.S., Lo S.S., et al. Complications following D3 gastrectomy: post hoc analysis of a randomized trial. World J Surg 2006, 30(1):12-16.
46. Degiuli M., Sasako M., Ponti A., et al. Survival results of a multicentre phase II study to evaluate D2 gastrectomy for gastric cancer. Br J Cancer 2004, 90(9):1727-1732.
47. Degiuli M., Sasako M., Ponti A., et al. Morbidity and mortality after D2 gastrectomy for gastric cancer: results of the Italian Gastric Cancer Study Group prospective multicenter surgical study. J Clin Oncol 1998, 16(4):1490-1493.
48. Sasako M., Sano S., Yamamoto A., et al. Randomized phase III trial of standard D2 versus D2 + para-aortic lymph node (PAN) dissection (D) for clinically M0 advanced gastric cancer: JCOG9501. J Clin Oncol 2006, 24(18-s, part II):934-s.
49. Sasako M., Sano T., Yamamoto S., et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008, 359(5):453-462.
50. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 2001, 345(10):725-730.
51. Hundahl S.A., Macdonald J.S., Benedetti J., et al. Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: the effect of undertreatment. Ann Surg Oncol 2002, 9(3):278-286.
52. Kampschoer G.H., Maruyama K., van de Velde C.J., et al. Computer analysis in making preoperative decisions: a rational approach to lymph node dissection in gastric cancer patients. Br J Surg 1989, 76(9):905-908.
53. Bollschweiler E., Boettcher K., Hoelscher A.H., et al. Preoperative assessment of lymph node metastases in patients with gastric cancer: evaluation of the Maruyama computer program. Br J Surg 1992, 79(2):156-160.
54. Guadagni S., de Manzoni G., Catarci M., et al. Evaluation of the Maruyama computer program accuracy for preoperative estimation of lymph node metastases from gastric cancer. World J Surg 2000, 24(12):1550-1558.
55. Siewert J.R., Kelsen D., Maruyama K., et al. Gastric cancer diagnosis and treatment - an interactive training program 2000, vol. 2000. Springer Electronic Media, Heidelberg (for Germans) and New York.
56. Hundahl SA, Macdonald JS, Benedetti J. Durable survival impact of " Low Maruyama Index Surgery" in a trial of adjuvant chemoradiation for gastric cancer. Alexandria (VA): American Society of Clinical Oncology, 2004 ASCO GI Symposium; 2004.
57. Peeters K.C., Hundahl S.A., Kranenbarg E.K., et al. " Low-Maruyama-Index" surgery for gastric cancer - a blinded re-analysis of the Dutch D1-D2 trial. World J Surg 2005, 29:1576-1584.
58. Hundahl S.A., Peeters K.C., Kranenbarg E.K., et al. Improved regional control and survival with " low Maruyama Index" surgery in gastric cancer: autopsy findings from the Dutch D1-D2 trial. Gastric Cancer 2007, 10(2):84-86.
59. Dikken J.L., Jansen E.P., Cats A., et al. Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancer. J Clin Oncol 2010, 28(14):2430-2436.
60. Baba M., Hokita S., Natsugoe S., et al. Paraaortic lymphadenectomy in patients with advanced carcinoma of the upper-third of the stomach. Hepatogastroenterology 2000, 47(33):893-896.
61. Isozaki H., Okajima K., Fujii K., et al. Effectiveness of paraaortic lymph node dissection for advanced gastric cancer. Hepatogastroenterology 1999, 46(25):549-554.
62. Maeta M., Saito H., Cai J., et al. Immunohistochemical detection of occult metastases in paraaortic lymph nodes in advanced gastric cancer. Oncol Rep 1999, 6(6):1233-1236.
63. Yonemura Y., Wu C.C., Fukushima N., et al. Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer. Int J Clin Oncol 2008, 13(2):132-137.
64. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355(1):11-20.
65. Sasako M., Saka M., Fukagawa T., et al. Gan To Kagaku Ryoho 2006, 33(Suppl 1):110-116. [in Japanese].
66. Sakuramoto S., Sasako M., Yamaguchi T., et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007, 357(18):1810-1820.
67. Jansen E.P., Boot H., Dubbelman R., et al. Postoperative chemoradiotherapy in gastric cancer-a phase I-II study of radiotherapy with dose escalation of weekly cisplatin and daily capecitabine chemotherapy. Ann Oncol 2010, 21(3):530-534.
68. Fujita J., Kurokawa Y., Sugimoto T., et al. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer 2011 May 15, [Epub ahead of print].
69. Sano T., Yamamoto S., Sasako M. Randomized controlled trial to evaluate splenectomy in total gastrectomy for proximal gastric carcinoma: Japan Clinical Oncology Group Study JCOG 0110-MF. Jpn J Clin Oncol 2002, 32(9):363-364.
70. Fujitani K., Yang H.K., Kurokawa Y., et al. Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01. Jpn J Clin Oncol 2008, 38(7):504-506.